Far-Infrared Ceramic Array for Deep Tissue Penetration
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current infrared light therapy, including red and near-infrared light, has limited penetration depth into the body due to significant energy dissipation, making it ineffective for treating deep-seated medical conditions such as neurodegenerative disorders, and existing far-infrared therapeutic devices fail to effectively target biochemical mechanisms in the body.
Innovation Solution
A therapeutic device featuring an array of IR-emitting ceramic elements with specific spectral luminance covering 3-14 μm wavelength spectrum, comprising two separate sets of elements emitting in the 3-7 μm and 7-14 μm ranges to enhance penetration and biochemical activation within the body.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Use of energy by moving object
If red or near-infrared light is used for therapy, then mitochondrial activity and cellular energy production are enhanced, but penetration depth into the body is limited to less than 5 mm
Solution Approach 1:
The patent changes the wavelength parameter of the infrared radiation from the conventional near-infrared range (700-1000 nm) to the far-infrared range (3-14 μm). This parameter change enables deeper tissue penetration while maintaining therapeutic effectiveness, as far-infrared radiation can penetrate several centimeters into biological tissues compared to the sub-millimeter penetration of near-infrared light.
Solution Approach 2:
The patent employs ceramic materials with specific compositional characteristics that emit far-infrared radiation in the 3-14 μm wavelength range. These composite ceramic materials are designed to optimize the emission spectrum to match the absorption characteristics of water and biological molecules, enabling both deep penetration and targeted biochemical activation.
2Length of stationary object
If far-infrared radiation is used to increase penetration depth, then deep tissue treatment is enabled, but specific biochemical mechanisms may not be effectively targeted
Solution Approach 1:
The patent optimizes the wavelength parameters of far-infrared radiation to specifically match the absorption bands of water (6.08 μm, 2.87 μm) and ATP (9.75-11.48 μm for P-O-P bonds, 8.33-9.09 μm for P=O bonds). This precise parameter matching enables selective activation of biochemical mechanisms deep within tissues, resolving the contradiction between penetration depth and biochemical targeting precision.
3Device complexity
If conventional infrared-emitting materials are used, then device simplicity is maintained, but spectral coverage and therapeutic effectiveness are insufficient
Solution Approach 1:
The patent uses composite ceramic materials containing specific metal oxides (such as barium titanate, strontium titanate, and other perovskite-type ceramics) that inherently emit broad-spectrum far-infrared radiation. This approach achieves comprehensive spectral coverage (3-14 μm) through material composition rather than complex multi-source device architecture, maintaining simplicity while enhancing therapeutic effectiveness.
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
The device achieves deeper tissue penetration and increased therapeutic benefits by simultaneously targeting molecular bonds and ATP hydrolysis, promoting healing and energy efficiency in the body without invasive procedures.
Implementation Method 1
a plurality of concave infrared-emitting ceramic elements in which 90% of the energy emitted is infrared radiation within a 3-14 μm wavelength spectrum with peak emissions within a 3-14 μm wavelength spectrum
Implementation Method 2
FIR Increases Harmonic Oscillations of Molecular Bonds while R-IR and NIR Increase Anharmonic Oscillations of Molecular Bonds. When molecules absorb radiation at R-IR or NIR wavelengths, the electromagnetic energy is converted to anharmonic vibrations in the molecule
Data Source
AI summary
This invention relates to a therapeutic device for treating a human or animal body, comprising an array of infrared-emitting elements disposed on or within a flexible substrate and attached to the body part to be treated using an attachment means, said array comprising a first plurality of infrared-emitting ceramic elements having a specific spectral luminance covering at least a part of the 3-7 micrometer wavelength spectrum and having a peak wavelength between 3 and 7 micrometers, and a second plurality of infrared-emitting ceramic elements having a specific spectral luminance covering at least a part of the 7-14 micrometer wavelength spectrum and having a peak wavelength between 7 and 14, that provides an effective means to healing the body.